GeNeDis 2014 - 1st World Congress on Geriatrics and Neurodegenerative Disease Research
Date2014-04-10 - 2014-04-13
Deadline2013-10-10
VenueCorfu, Greece
Keywords
Websitehttps://www.genedis.eu/
Topics/Call fo Papers
The 1st World Congress on Geriatrics and Neurodegenerative Disease Research, GeNeDis 2014 (Geriatrics and Neurodegenerative Disease) will focus on recent advances in geriatrics and neurodegeneration, ranging from basic science to clinical and pharmaceutical developments and will provide an international forum for the latest scientific discoveries, medical practices and care initiatives.
Nobel laureates, leading scientists and experts, students, physicians and nurses, professionals and many others participants will discuss the latest major challenges, new drug targets, the development of new biomarkers, imaging techniques, novel protocols for early diagnosis of neurogenerative diseases and several other scientific achievements.
While the European Union aim to strength the research and innovation towards Horizon 2020, the translational research for health aging and neurodegeneration will remove any barrier on multi-disciplinary collaboration. Novel approaches include biomarkers, stem cell therapy, protein misfolding, immunotherapy, as well as developments in our understanding of the genetics, the molecular mechanisms and signalling pathways contributing to neuronal dysfunction, nanotechnological products and innovate computational methods will offer new research directions and strategies on future preclinical and clinical studies on neurodegenerative diseases and related disorders, as well as improving of quality services on rehabilitation and health education.
Advanced information technologies will be discussed concerning the various research, implementation, and policy, as well as European and global issues in the funding of long-term care and medico-social policies regarding elderly people.
Nobel laureates, leading scientists and experts, students, physicians and nurses, professionals and many others participants will discuss the latest major challenges, new drug targets, the development of new biomarkers, imaging techniques, novel protocols for early diagnosis of neurogenerative diseases and several other scientific achievements.
While the European Union aim to strength the research and innovation towards Horizon 2020, the translational research for health aging and neurodegeneration will remove any barrier on multi-disciplinary collaboration. Novel approaches include biomarkers, stem cell therapy, protein misfolding, immunotherapy, as well as developments in our understanding of the genetics, the molecular mechanisms and signalling pathways contributing to neuronal dysfunction, nanotechnological products and innovate computational methods will offer new research directions and strategies on future preclinical and clinical studies on neurodegenerative diseases and related disorders, as well as improving of quality services on rehabilitation and health education.
Advanced information technologies will be discussed concerning the various research, implementation, and policy, as well as European and global issues in the funding of long-term care and medico-social policies regarding elderly people.
Other CFPs
Last modified: 2013-08-26 22:13:14